M&R Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $158K | Hold |
150
| – | – | 0.03% | 151 |
|
|
2024
Q2 | $158K | Hold |
150
| – | – | 0.04% | 147 |
|
|
2024
Q1 | $145K | Hold |
150
| – | – | 0.04% | 150 |
|
|
2023
Q4 | $132K | Hold |
150
| – | – | 0.03% | 176 |
|
|
2023
Q3 | $123K | Hold |
150
| – | – | 0.03% | 169 |
|
|
2023
Q2 | $108K | Hold |
150
| – | – | 0.03% | 181 |
|
|
2023
Q1 | $123K | Hold |
150
| – | – | 0.03% | 168 |
|
|
2022
Q4 | $108K | Sell |
150
-90
| -38% | -$64.9K | 0.03% | 182 |
|
|
2022
Q3 | $165K | Hold |
240
| – | – | 0.05% | 149 |
|
|
2022
Q2 | $141K | Hold |
240
| – | – | 0.04% | 166 |
|
|
2022
Q1 | $167K | Buy |
240
+200
| +500% | +$139K | 0.04% | 159 |
|
|
2021
Q4 | $25K | Hold |
40
| – | – | 0.01% | 286 |
|
|
2021
Q3 | $24K | Hold |
40
| – | – | 0.01% | 289 |
|
|
2021
Q2 | $22K | Hold |
40
| – | – | 0.01% | 299 |
|
|
2021
Q1 | $18K | Buy |
40
+15
| +60% | +$6.75K | ﹤0.01% | 294 |
|
|
2020
Q4 | $12K | Buy |
+25
| New | +$12K | ﹤0.01% | 338 |
|